ILD patient cases for evaluation and diagnosis
Patients like Ben, Caroline and Robert should raise suspicion that requires evaluation for ILD
![ILD patients with the HRCT scans in their hands.](/sites/default/files/2021-08/Hero-Pulms-desktop-1280x440px-BEN.png)
Download our patient cases for specific ILDs to find about the medical histories of representative patients, including risk factors, presenting symptoms, initial physical evaluations, and HRCT diagnostic findings.
![Picture of Robert, IPF patient.](/sites/default/files/2021-07/01-elements-placeholder-card-1-1%402x_5.png)
Ben has IPF
What signs and symptoms raise suspicion of IPF?
![Picture of Caroline, IPF patient.](/sites/default/files/2021-07/01-elements-placeholder-card-1-1%402x_6.png)
Caroline has IPF
How can you build a clinical picture of IPF?
![Picture of Robert, cHP patient.](/sites/default/files/2021-07/01-elements-placeholder-card-1-1%402x_15.png)
What are the next steps for patients like Ben, Caroline and Robert after diagnosis?
![Spirometer and HRCT scan graphics.](/sites/default/files/2021-07/01-elements-placeholder-card-16-9%402x_4.png)
Monitoring ILD progression
![Blurred scheme of NON-IPF ILDs management algorithm.](/sites/default/files/2021-07/01-elements-placeholder-card-16-9%402x_6.png)
Interventions for ILDs
![Scheme representing the approaches available to support patients with ILD.](/sites/default/files/2021-07/01-elements-placeholder-card-16-9%402x_7.png)
Providing palliative/supportive care
Footnotes
-
cHP, chronic hypersensitivity pneumonitis; HRCT, high-resolution computed tomography; ILD, interstitial lung disease; IPF, idiopathic pulmonary fibrosis; PFT, pulmonary function test.
-
Raghu G, Collard HR, Egan JJ, et al; on behalf of the ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788-824.
-
Maher TM, Molina-Molina M, Russell AM, et al. Unmet needs in the treatment of idiopathic pulmonary fibrosis-insights from patient chart review in five European countries. BMC Pulm Med. 2017;17(1):124.
-
Molina-Molina M, Aburto M, Acosta O, et al. Importance of early diagnosis and treatment in idiopathic pulmonary fibrosis. Exp Rev Resp Med. 2018;12(7):537–539.
-
Robalo-Cordeiro C, Campos P, Carvalho L, et al. Idiopathic pulmonary fibrosis in the era of antifibrotic therapy: Searching for new opportunities grounded in evidence. Rev Port Pneumol. 2017;23(5):287–293.
-
Ryerson CJ, Cayou C, Topp F, et al. Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort study. Respir Med. 2014;108(1):203-210.
-
Kreuter M, Bendstrup E, Russell A, et al. Palliative care in interstitial lung disease: living well. Lancet Respir Med. 2017;5(12):968-980.
-
Maher TM, Wuyts W. Management of Fibrosing Interstitial Lung Diseases. Adv Ther. 2019;doi:10.1007/s12325-019-00992-9. [Epub ahead of print].
-
Sgalla G, Cerri S, Ferrari R, et al. Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy. BMJ Open Respir Res. 2015;2(1):e000065.
Resources for patients
![Two seniors smiling together.](/sites/default/files/2021-07/image.png)
![Life with Pulmonary Fibrosis website logo.](/sites/default/files/2021-07/logo-primary_0.png)
![Scleroderma female patient looking into the window.](/sites/default/files/2021-07/image_0.png)
![More then scleroderma website logo.](/sites/default/files/2021-07/logo-primary_1.png)